FDA urges consumers and distributors to stop using and selling both products immediately
U.S. Food and Drug Administration is warning consumers, retailers, and distributors not to eat, sell, or distribute the Addall XR Shot or Addall XL dietary supplement capsules, both marketed by ZMB Enterprises, LLC of Carlsbad, California. FDA testing found unlawful and undeclared stimulant and psychoactive ingredients in both products.
FDA laboratory results showed the Addall XR Shot contains undeclared 1,4‑DMAA and phenibut, a substance not permitted in dietary supplements. The Addall XL capsules were found to contain undeclared 1,4‑DMAA and DMHA, another stimulant that is not a lawful ingredient.
The FDA notified the company on January 6, 2026, recommending a recall of both products. ZMB Enterprises agreed to recall only the Addall XR Shot and stated it would discontinue the use of phenibut. The firm declined to recall Addall XL capsules, prompting the FDA to issue a broader public health alert.
According to the agency, DMAA and DMHA can sharply raise blood pressure and may trigger shortness of breath or heart attack. Phenibut can cause impaired balance, extreme fatigue, loss of consciousness, and carries addiction risks. Using these products, especially at high doses or in combination with other substances may lead to life‑threatening complications.
Consumers are urged to dispose of both products immediately and contact a healthcare provider if they experience symptoms. The FDA will update this alert as new information becomes available.
© 2026 BCDollarSaver.com. All rights reserved.
Be the first to comment